Brief: Interpace Announces New Agreement With SelectHealth
July 22 (Reuters) - Interpace Diagnostics Group Inc
IDXG.O :
* INTERPACE ANNOUNCES NEW AGREEMENT WITH SELECTHEALTH
* INTERPACE DIAGNOSTICS - REACHED AGREEMENT WITH
SELECTHEALTH TO
PROVIDE THYROID CANCER ASSAYS TO SELECTHEALTH'S MEMBERS IN UTAH
& IDAHO
Source text for Eikon: ID:nGNXGnpW5
Further company coverage: IDXG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million